PrevenTest > For Providers

Tumor Molecular Testing > For Neuroblastoma / Medulloblastoma Cancer

 

The Time Is Now

Personalized Treatment Designed For Cancer Patients

Neuroblastoma and Medulloblastoma Cancer Panel

Neurobalstoma accounts for 15% of all pediatric cancer deaths in the United Stated. Medulloblastoma accounts for 15-20% of all pediatric brain tumors. Both diseases are characterized by aggressive, invasive, and deadly nature. People with familial cancer syndromes are at a higher risk to develop brain carcinoma. 

Genes and Their Locations

ALK
MGMT1
ERCC1
TOPO1
PTCH1
TP53
RRM1
PGP
SMO
CTNNB1
1p19q

Why GeneID Molecular Tumor Testing?